- Home
- / Osmotica Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Osmotica Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.9
2022-03-22
Market Capitalization
$92.5 M
2022-03-22
Revenue
$49.7 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 170.5M | 237.7M | 263.7M | 240.0M | 177.9M | 17.5M | 49.7M |
| Revenue growth, % | 39.4% | ||||||
| Cost of goods sold | 125.6M | 125.2M | 135.0M | 111.6M | 74.5M | 3.6M | 9.5M |
| Gross profit | 44.9M | 112.5M | 128.7M | 128.4M | 103.4M | 13.9M | 40.3M |
| Gross profit margin, % | 26.3% | 47.3% | 48.8% | 53.5% | 58.1% | 81.0% | |
| General and administrative expense | 66.0M | 57.0M | 74.2M | 93.0M | 82.0M | 87.5M | 82.0M |
| Operating expense total | 103.4M | 99.6M | 227.2M | 409.1M | 173.8M | 96.6M | 99.3M |
| Depreciation and amortization | 21.5M | 73.0M | |||||
| EBIT | (32.0M) | (52.1M) | (98.5M) | (280.7M) | (70.4M) | (82.8M) | (59.0M) |
| EBIT margin, % | -18.8% | -21.9% | -37.4% | -116.9% | -39.6% | -118.6% | |
| Interest expense | 20.2M | 29.1M | 20.8M | 18.2M | 14.4M | 3.0M | 3.1M |
| Pre tax profit | (52.1M) | (85.6M) | (118.7M) | (298.0M) | (84.3M) | (82.5M) | (51.7M) |
| Income tax expense | (10.2M) | (40.5M) | (9.3M) | (27.1M) | (4.7M) | (315.0K) | 20.0K |
| Net Income | (41.8M) | (45.2M) | (109.4M) | (270.9M) | (79.6M) | (64.9M) | (51.7M) |
| EPS | (0.6) |